These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10199391)

  • 1. HIV Tat represses transcription of the beta 2-microglobulin promoter.
    Carroll IR; Wang J; Howcroft TK; Singer DS
    Mol Immunol; 1998 Dec; 35(18):1171-8. PubMed ID: 10199391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Tat represses transcription from the mannose receptor promoter.
    Caldwell RL; Egan BS; Shepherd VL
    J Immunol; 2000 Dec; 165(12):7035-41. PubMed ID: 11120831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.
    Rittner K; Churcher MJ; Gait MJ; Karn J
    J Mol Biol; 1995 May; 248(3):562-80. PubMed ID: 7752225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class I genes.
    Weissman JD; Brown JA; Howcroft TK; Hwang J; Chawla A; Roche PA; Schiltz L; Nakatani Y; Singer DS
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11601-6. PubMed ID: 9751712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of MHC class I gene promoter activity by two-exon Tat of HIV.
    Howcroft TK; Strebel K; Martin MA; Singer DS
    Science; 1993 May; 260(5112):1320-2. PubMed ID: 8493575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of tumor necrosis factor-beta expression by the human immunodeficiency virus type-1 tat protein in central nervous system-derived glial cells.
    Yang L; Morris GF; Wang Z; Bohan Morris C
    Virus Res; 1997 Aug; 50(2):195-203. PubMed ID: 9282784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV Tat protein requirements for transactivation and repression of transcription are separable.
    Brown JA; Howcroft TK; Singer DS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jan; 17(1):9-16. PubMed ID: 9436753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression in vitro, by human adenovirus E1A protein domains, of basal or Tat-activated transcription of the human immunodeficiency virus type 1 long terminal repeat.
    Song CZ; Loewenstein PM; Green M
    J Virol; 1995 May; 69(5):2907-11. PubMed ID: 7707515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAR- and Tat-independent replication of human immunodeficiency virus type 1 in human hepatoma cells.
    Zhu M; Duan L; Pomerantz RJ
    AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1093-101. PubMed ID: 8844014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.
    García-Martínez LF; Mavankal G; Peters P; Wu-Baer F; Gaynor RB
    J Mol Biol; 1995 Dec; 254(3):350-63. PubMed ID: 7490754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of HIV-1 regulatory proteins on cellular genes: derepression of the IL-2 promoter by Tat.
    Ehret A; Li-Weber M; Frank R; Krammer PH
    Eur J Immunol; 2001 Jun; 31(6):1790-9. PubMed ID: 11385624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
    Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV Tat represses transcription through Sp1-like elements in the basal promoter.
    Howcroft TK; Palmer LA; Brown J; Rellahan B; Kashanchi F; Brady JN; Singer DS
    Immunity; 1995 Jul; 3(1):127-38. PubMed ID: 7621073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
    Kamine J; Subramanian T; Chinnadurai G
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of the histone-acetyltransferase activity of Tip60 by the HIV-1 transactivator protein, Tat.
    Creaven M; Hans F; Mutskov V; Col E; Caron C; Dimitrov S; Khochbin S
    Biochemistry; 1999 Jul; 38(27):8826-30. PubMed ID: 10393559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter.
    Berkhout B; Gatignol A; Rabson AB; Jeang KT
    Cell; 1990 Aug; 62(4):757-67. PubMed ID: 2201451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The octamer-binding proteins Oct-1 and Oct-2 repress the HIV long terminal repeat promoter and its transactivation by Tat.
    Liu YZ; Latchman DS
    Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):155-8. PubMed ID: 9078256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bimolecular mechanism of HIV-1 Tat protein interaction with RNA polymerase II transcription elongation complexes.
    Zhou C; Rana TM
    J Mol Biol; 2002 Jul; 320(5):925-42. PubMed ID: 12126615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.